7,421,517 results
Page 4 of 100
6-K
BNTX
BioNTech SE
25 Feb 21
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
6-K
IMRN
Immuron Limited
25 Feb 21
Report of Foreign Private Issuer
8-K
CWH
Camping World Holdings Inc
25 Feb 21
Results of Operations and Financial Condition
8-K
ITCI
Intra-Cellular Therapies Inc
25 Feb 21
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Corporate Update
20-F
2020 FY
MDWD
MediWound Ltd
25 Feb 21
Annual report (foreign)
8-K
EDIT
Editas Medicine Inc
25 Feb 21
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
D
JO Fund I, a series of AngelList-GP-Funds-I, LP
25 Feb 21
$85.48K in investment fund, sold $85.48K, 22 investors
8-K
SHOO
Steven Madden Ltd.
25 Feb 21
Results of Operations and Financial Condition
8-K
LAWS
Lawson Products, Inc.
25 Feb 21
Lawson Products Reports Fourth Quarter and Full Year 2020 Results
8-K
PMTS
CPI Card Group Inc.
25 Feb 21
CPI Card Group Inc. Announces Proposed Private Offering of $310 Million of Senior Secured Notes
10-K
2020 FY
ITCI
Intra-Cellular Therapies Inc
25 Feb 21
Annual report
NPORT-P
Federated Core Trust III
25 Feb 21
Project and Trade Finance Core Fund f/k/a Federated Project and Trade Finance Core Fund (Dec 2020 report)
8-K
SAFM
Sanderson Farms, Inc.
25 Feb 21
Sanderson Farms, Inc. Reports Results for First Quarter of Fiscal 2021
FWP
GROY
Gold Royalty Corp.
25 Feb 21
Free writing prospectus
D
RI Fund I, a series of DV Collective, LP
25 Feb 21
$101.5K in investment fund, sold $101.5K, 29 investors
8-K
PLTK
Playtika Holding Corp
25 Feb 21
Playtika Holding Corp. Reports Fourth Quarter 2020 Results
8-K
NTLA
Intellia Therapeutics Inc
25 Feb 21
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
6-K
GSK
Glaxosmithkline plc
25 Feb 21
GSK Announces Otilimab Data for Treatment of Covid
8-K
PLAN
Anaplan Inc
25 Feb 21
Anaplan Announces Fourth Quarter and Full
10-K
2020 FY
PRVB
Provention Bio Inc
25 Feb 21
Annual report